Bausch Health Companies (BHC) Non-Current Deffered Revenue (2009 - 2012)

Bausch Health Companies (BHC) reported Non-Current Deffered Revenue of $36.1 million for Q4 2012, down 5.31% on a YoY basis from $38.2 million in Q1 2012, and down 1.63% sequentially from $36.7 million in Q3 2012.

Bausch Health Companies (BHC) Non-Current Deffered Revenue (2009 - 2012) Analysis & Trends

Bausch Health Companies (BHC) has 4 years of Non-Current Deffered Revenue data on file, last reported at $36.1 million in Q4 2012.

  • For the quarter ending Q4 2012, Non-Current Deffered Revenue fell 5.31% year-over-year to $36.1 million; the trailing twelve-month figure through Dec 2012 stood at $36.1 million (down 5.31% YoY), and the FY2012 full-year result was $36.1 million, down 5.31% from the prior year.
  • Non-Current Deffered Revenue fell to $36.1 million in Q4 2012, from $36.7 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $69.2 million in Q4 2009 to a low of $34.0 million in Q1 2012.
  • A 4-year average of $45.5 million and a median of $42.0 million in 2011 frame the typical range for Non-Current Deffered Revenue.
  • Across the five-year window, Non-Current Deffered Revenue declined 28.5% in 2011 and slipped 5.31% in 2012, its largest moves.
  • Tracing BHC's Non-Current Deffered Revenue over 4 years: stood at $69.2 million in 2009, then dropped by 27.76% to $50.0 million in 2010, then slipped by 23.73% to $38.2 million in 2011, then slipped by 5.31% to $36.1 million in 2012.
  • Business Quant data shows BHC's Non-Current Deffered Revenue at $36.1 million in Q4 2012, $36.7 million in Q3 2012, and $37.9 million in Q2 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2012 36.13 Mn
Sep 30, 2012 36.73 Mn
Jun 30, 2012 37.90 Mn
Mar 31, 2012 33.97 Mn
Dec 31, 2011 38.15 Mn
Sep 30, 2011 41.41 Mn
Jun 30, 2011 42.51 Mn
Mar 31, 2011 45.02 Mn
Dec 31, 2010 50.02 Mn
Sep 30, 2010 55.03 Mn
Jun 30, 2010 59.45 Mn
Dec 31, 2009 69.25 Mn